Option Care Health (OPCH) Proxy filing summary

Executive summary

• Achieved 13% net revenue growth to $5.65 billion and 6.2% adjusted EBITDA growth in 2025, with strong operational and financial performance.

• Deployed over $460 million into investments, including acquisitions and share repurchases, and generated $258 million in operating cash flow.

• Leadership changes included the appointment of a new CFO and the departure of two long-serving directors.

• Stockholders approved enhancements to governance, including the right to request special meetings.

Voting matters and shareholder proposals

• Election of nine director nominees for terms expiring at the 2027 annual meeting.

• Ratification of KPMG LLP as independent registered public accounting firm for 2026.

• Advisory vote to approve named executive officer compensation (say-on-pay).

Board of directors and corporate governance

• Board consists of nine nominees, with five joining since 2022, and all but the CEO are independent.

• Board committees include Audit and Finance, Compensation, Nominating and Corporate Governance, and Quality, Technology and Compliance.

• Governance highlights: one share/one vote, annual director elections, independent chair, proxy access, and stockholder-called special meetings.

• Board and committee self-evaluations conducted annually; robust director orientation and education programs.